Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
Public ClinicalTrials.gov record NCT05177107. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2b Randomized, Parallel, Double-blind, Placebo-Controlled, Repeat Dose, Multi-Site Study for Safety, Tolerability, and Efficacy of Personalized Phage Treatment and SoC for Subjects With Diabetic Foot Osteomyelitis Due to S. Aureus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2b randomized trial designed to evaluate bacteriophage therapy in subjects with diabetic foot osteomyelitis.
Study identification
- NCT ID
- NCT05177107
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 24, 2021 (Actual)
- Primary completion
- Jan 30, 2025 (Actual)
- Completion
- May 30, 2025 (Actual)
- Last update posted
- Aug 19, 2025
2021 – 2025
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern Arizona VA Health Care System | Tuscon | Arizona | 85723 | — |
| NorthBay Healthcare | Fairfield | California | 94534 | — |
| Harbor Hospital / UCLA | Torrance | California | 90502 | — |
| Rocky Mountain VA | Aurora | Colorado | 80045 | — |
| Holy Cross Health | Fort Lauderdale | Florida | 33308 | — |
| Infectious Disease Consultants od the Treasure Coast | Sebastian | Florida | 32958 | — |
| Podiatry 1st / Gateway Clinical Trials | O'Fallon | Illinois | 62269 | — |
| Foot & Ankle Center of Illinois | Springfield | Illinois | 62704 | — |
| Henry Ford Health | Detroit | Michigan | 48202 | — |
| Holy Name Medical Center | Teaneck | New Jersey | 07666 | — |
| CurAlta Foot and Ankle | Westwood | New Jersey | 07675 | — |
| Futuro Clinical Trials, LLC | McAllen | Texas | 78501 | — |
| Bio X Cell Research LLC | San Antonio | Texas | 78224 | — |
| Foot and Ankle Specialists of the Mid-Atlantic | Salem | Virginia | 24153 | — |
| Salem VA | Salem | Virginia | 24153 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05177107, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05177107 live on ClinicalTrials.gov.